News

ND-BioSciences awarded a new grant from The Michael J. Fox Foundation to develop more accurate and sensitive assays for quantifying α-Synuclein

Epalinges, 26 November 2019
ND BioSciences, a Swiss-based biotechnology company that was founded with the mission of accelerating the development of early diagnostics and therapies for neurodegenerative diseases, today announced that it has received a new grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF).

ND-BioSciences awarded a grant from The Michael J. Fox Foundation to help advance the foundation’s α-Synuclein biomarkers discovery and validation programs

Epalinges, 1 October 2019
ND BioSciences, a Swiss-based biotechnology company that was founded with the mission of accelerating the development of early diagnostics and therapies for neurodegenerative diseases, today announced that The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has awarded a grant of for its Protein Science and Discovery program.